510(k) device
iLet Dosing Decision Software
Beta Bionics, Inc. · Interoperable Automated Glycemic Controller (QJI, Class II) · First FDA decision May 19, 2023, newest Sep 11, 2026Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
1
Naming "iLet Dosing Decision"
MAUDE reports
2
Brand "iLet Dosing Decision", since 2015
PubMed studies
0
Mentioning "iLet Dosing Decision"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing iLet Dosing Decision Software
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K262763 · Decided Sep 11, 2026 · 38 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
K232224 · Decided Sep 22, 2023 · 57 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
K220916 · Decided May 19, 2023 · 415 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "iLet Dosing Decision", any status and sponsor, newest update first.
- The iLet Experience StudyRecruiting
Beta Bionics, Inc.Not on our public-company list
NCT06891898 · 1,875 participants (planned) · Start May 1, 2024 · Primary completion Jun 2027
Device: iLet Dosing Decision Software · For: Type 1 Diabetes
Sites: Irvine, California
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "iLet Dosing Decision", and for the whole product code for context.
This brand
2 reports: 1 malfunction, 0 injury, 1 death
Whole product code QJI
5,524 reports: 3,680 malfunction, 1,836 injury, 4 death
Newest reports for this brand
MW5172082 · Received Jun 30, 2025
Device type: Interoperable Automated Glycemic Controller (QJI)
Device problem as coded: Failure to Sense; Failure to Deliver
Patient problem as coded: Insufficient Information
- ILET DOSING DECISION SOFTWAREMalfunction
MW5167708 · Received Mar 17, 2025 · Event dated Mar 10, 2025
Device type: Interoperable Automated Glycemic Controller (QJI)
Patient problem as coded: Hyperglycemia
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- iLet Ace Pump Kit REF: BB1001 iLet Dosing Decision SoftwareOpen, Classified
Z-1809-2026 · Started Aug 13, 2025 · Posted by FDA Apr 10, 2026
Reason given: it was found that in versions 1.3.7, 1.4.2, and 1.4.3, the Lock Screen and Limited Access Passcode Screen on the iLet graphical user interface (GUI) include certain icons displayed in the status bar that are active, thereby allowing the user to bypass those screens when those icons on the status bar are pressed,...
Cause as FDA categorized it: Software design · Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG)
Published research
The most relevant PubMed records for "iLet Dosing Decision"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QJI.
- SmartGuard TechnologyMedtronic MiniMed · 510(k) 2026
- SmartAdjust TechnologyInsulet Corporation · 510(k) 2024
- Control-IQ+ technologyTandem Diabetes Care, Inc. · 510(k) 2026
- Control-IQ TechnologyTandem Diabetes Care, Inc. · De Novo 2023
- twiist Loop AlgorithmDeka Research and Development Corp. · 510(k) 2026
- iOS CamAPS FXCamDiab · 510(k) 2026
- Omnipod 6 algorithmInsulet Corporation · 510(k) 2026
- DBLG2Diabeloop · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.